News MHRA unveils big shakeup in UK clinical trials regs Reforms will make applications streamlined and flexible without affecting safety, says agency.
News Novo Nordisk suspended from ABPI after code breach The two-year ban reflects "serious breaches” of the trade organisation’s code of practice.
News UK Chancellor’s budget welcomed by biopharma sector Industry groups are happy with news on R&D tax credits, funding for MHRA, and investment zones.
News Pfizer’s Susan Rienow named new president of ABPI Appointment follows the exit of Novo Nordisk's Pinder Sahota, after firm's ABPI code breaches.
News Dismay as UK raises clawback rate on NHS drug spending Rise in rate to 27.5% from 1st April will damage the UK economy, claim senior industry figures.
News UK launches review of clinical trials amid worrying decline Review comes after drug industry saw a 41% decline in new trial starts between 2017 and 2021.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.